Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

Name: Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
Published: 2010
License: Public Domain

National Cancer Institute (NCI) · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

gastrin-producing neuroendocrine tumor, lung carcinoid tumor, metastatic digestive system neuroendocrine tumor g1, pancreatic glucagonoma, pancreatic insulinoma, pancreatic polypeptide tumor, paraganglioma, recurrent digestive system neuroendocrine tumor g1, recurrent merkel cell carcinoma, recurrent pancreatic neuroendocrine carcinoma, regional digestive system neuroendocrine tumor g1, somatostatin-producing neuroendocrine tumor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 865303
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.